About diagnosis and therapy of bipolar disorder

Close metadata

Recommended articles:

A perspective on the application of CRISPR/CAS9 genome editing system to study of molecular-genetic basis of mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33

Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model). S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):36-42

Cognitive impairment in cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16

Cognitive behavioral therapy in the treatment of patients with chronic migraine and concomitant chronic insomnia: a prospective, randomized trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):110-117

Late-onset schizophrenia and schizophrenia-like psychosis with very late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):32-40

An individual approach to the diagnosis and treatment of an acute psychotic condition in a patient with a multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):97-102

Respiratory-syncitial virus: biology, genetic diversity and perspective control preparations. Molecular Genetics, Microbiology and Virology. 2024;(1):16-24

Relapse of primary mediastinal B-cell lymphoma with isolated central nervous system involvement: risk factors and search for personalized therapy. P.A. Herzen Journal of Oncology. 2024;(2):39-45

Human diseases treatment via enema fecal microbiota transplantation. Methodological recommendations. Russian Journal of Preventive Medicine. 2024;(6):79-87

Unresolved problem: Chemotherapy-Induced Peripheral Neuropathy. P.A. Herzen Journal of Oncology. 2024;(5):76-81

The author describes diagnostic criteria and clinical symptoms of bipolar affective disorder (BAD) and summarizes the results of clinical studies on using modern antipsychotics to optimize BAD treatment. Preliminary recommendations for the use of aripiprazole in treatment of BAD, including exacerbation therapy and long-term maintenance therapy to prevent relapses, are presented.

Keywords:

bipolar disorder

therapy

augmentation

atypical antipsychotics

aripiprazole

Authors:

Barkhatova A.N.

Mental Health Research Center

Received:

27.01.2021

Accepted:

02.02.2021

List of references:

Mosolov SN, Kostyukova EG, Kuzavkova MV. Bipolyarnoe affektivnoe rasstrojstvo: diagnostika i terapiya. Pod red. Mosolova S.N. M.: MEDpress-inform; 2008. (In Russ.).
Kupfer DJ. Increasing medical burden in bipolar disorder. JAMA. 2005;293(20):2528-2530. https://doi.org/10.1001/jama.293.20.2528
McDonald KC, Bulloch AGM, Duffy A, Bresee L, Williams J, Lavorato D. Patten Prevalence of bipolar I and II disorder in Canada. Can J Psychiatry. 2015;60:151-156. https://doi.org/10.1177/070674371506000310
Bauer M, Glenn T, Alda M, Andreassen O, Angelopoulos E, Ardau R, Baethge C, Bauer R, Bellivier F, Belmaker RH, Berk M, Bjella TD, Bossini, Bersudsky Y, Cheung E, Conell J, Del Zompo M, Dodd S, Etain B, Fagiolini A, Frye M, Fountoulakis K, Garneau-Fournier J, Gonzalez-Pinto A, Harima H, Hassel, Henry C, Iacovides A, Isometsä E, Kapczinski F, Kliwick S, König B, Krogh R, Kunz M, Lafer B, Larsen, Lewitzka U, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Monteith S, Morken G, Munoz R, Nery FG, O’Donovan C, Osher Y, Pfennig A, Quiroz, Ramesar R, Rasgon N, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Scippa AM, Severus E, Simhandl C, Stein DJ, Strejilevich S, Hatim Sulaiman A, Suominen K, Tagata H, Tatebayashi Y, Torrent C, Vieta E, Viswanath B, Wanchoo MJ, Zetin M, Whybrow PC. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. Eur Psychiatry. 2015;30:99-105. https://doi.org/10.1016/j.eurpsy.2014.10.005
Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand. 1989;79:136-147. https://doi.org/10.1111/j.1600-0447.1989.tb08581.x
Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M. Lifetime and sixmonth prevalence of mental disorders in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci. 1992;241:247-258. https://doi.org/10.1007/BF02190261
Hirschfeld RMA, Holzer C, Calabrese JR, Weissman M, Reed M, Davies M, Frye MA, Keck P, McElroy S, Lewis L, Tierce J, Wagner KD, Hazard E: Validity of the Mood Disordr Questionnaire: A general population study. Am J Psychiatry. 2003;160:178-180. https://doi.org/10.1176/appi.ajp.160.1.178
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DMS-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:18-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Diagnostic issues in bipolar disorder. Europ Neuropsychopharm. 2003;13:43-50. https://doi.org/10.1016/S0924-977X(03)00077-4
Mosolov SN, Kostyukova EG, Kuzavkova MV. Profilakticheskoe primenenie antikonvul’santov pri faznoprotekayushchih endogennyh psihozah (sravnitel’noe izuchenie karbamazepina, val’proata natriya i solej litiya). V kn.: Antikonvul’santy v psihiatricheskoj i nevrologicheskoj praktike. Pod red. Vejn A.M., Mosolov S.N. Medicinskoe informacionnoe agentstvo; S-P; 1994;72-128. (In Russ.).
Mosolov SN, Kostyukova EG. Bipolyarnoe affektivnoe rasstrojstvo. Nacional’noe rukovodstvo. Psihiatriya pod rkd. Aleksandrovskij Yu.A., Neznanov N.G. Geotar Media; 2018;704-799. (In Russ.).
World Health Organization. The World Health Report 2001; Mental Health: New Understanding, New Hope. Geneva, WHO, 2001.
Joyce K, Thompson A, Marwaha S. Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review [Elektronnyi resurs]. International Journal of Bipolar Disorders. 2016;4(1). https://doi.org/10.1186/s40345-016-0060-6
Bauer MS, Kirk GF, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high intensity follow-up study. J Affect Disord. 2001;65:231-241. https://doi.org/10.1016/s0165-0327(00)00247-0
Dong M, Li Lu, Ling Zhang, Qinge Zhang, Gabor S, Ungvari, Chee H Ng, Zhen Yuan, Yifan Xiang, Gang Wang, Yu-Tao Xiang. Prevalence of suicide attempts in bipolar disorder: a systematic review and meta-analysis of observational studies. Epidemiology and Psychiatric Sciences. 2019;1-9. https://doi.org/10.1017/S2045796019000593
Koukopoulos AG, Sani G, Manfredi I, Pacchiarotti P, Girardi. Acta Psychiatr Scand. 2007;433:50-57. https://doi.org/10.1111/j.1600-0447.2007.00963.x
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, David J Bond, Benicio N Frey, Verinder Sharma, Benjamin I Goldstein, Soham Rej, Serge Beaulieu, Martin Alda, Glenda MacQueen, Roumen V Milev, Arun Ravindran, Claire O’Donovan, Diane McIntosh, Raymond W Lam, Gustavo Vazquez, Flavio Kapczinski, Roger S McIntyre, Jan Kozicky, Shigenobu Kanba, Beny Lafer, Trisha Suppes, Joseph R Calabrese, Eduard Vieta, Gin Malhi, Robert M Post and Michael Berk, «Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders» (ISBD), 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170. https://doi.org/10.1111/bdi.12609
Swann AC, Lafer B, Perugi G, et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. American Journal of Psychiatry. 2013;170(1):31-42. https://doi.org/10.1176/appi.ajp.2012.12030301
Calabrese JR, Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. Journal of Clinical Psychiatry. 2004;65:1499-1504. https://doi.org/10.4088/jcp.v65n1109
Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Health Technol Assess. 2004;8(19):iii-iv:1-187. PMID: 15147609. https://doi.org/10.3310/hta8190
Keck PE Jr, Calabrese JR, McIntyre RS, McQuade R, Carson W, Eudicone J, Carlson B, Marcus R, Sanchez R. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100week, doubleblind study versus placebo. J Clin Psychiatry. 2007;68(10):14801491. https://doi.org/10.4088/jcp.v68n1003
Thase ME, Jonas A, Khan A, Bowden C, Wu X, McQuade R, Carson W, Marcus R, Owen R. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebocontrolled studies. J Clin Psychopharmacol. 2008;28(1):1320. https://doi.org/10.1097/jcp.0b013e3181618eb4
Derry S, Moore RA. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry. 2007;740. https://doi.org/10.1186/1471-244X-7-40
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Muller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry. 2009;10:85116. https://doi.org/10.1080/15622970902823202
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Muller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP] Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14:154-219. https://doi.org/10.3109/15622975.2013.770551
Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Furukawa TA. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. CNS Drugs. 2014;28. https://doi.org/10.1007/s40263-014-0197-8
Bellantuono C., Di Massimo G., Mauro A., Martellini M., Nardi B. Aripiprazole in pregnancy: a review of literature. Riv Psichiatr. Jan-Feb 2015;50(1):8-11. PMID: 25805349 https://doi.org/10.1708/1794.19526.

Close metadata